Daniel L. Alkon

Insider Reports History

Entity
Individual
Location
C/O Neurotrope, Ine., 205 East 42 Nd Street 20 Th Floor, New York, NY
Signature
/s/ Robert Weinstein, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Daniel L. Alkon:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Synaptogenix, Inc. President and CSO, Director Common Stock, par value $0.0001 per share 35.5K $41.7K $1.17 Dec 16, 2022 Direct

Insider Reports Filed by Daniel L. Alkon

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SNPX Synaptogenix, Inc. Dec 16, 2022 1 -$23.1K 4 Dec 20, 2022 President and CSO, Director
SNPX Synaptogenix, Inc. Nov 15, 2022 1 $0 4/A Dec 1, 2022 President and Chief Scientific Officer, Director
SNPX Synaptogenix, Inc. Jul 13, 2021 1 $0 4/A Dec 1, 2022 President and CSO, Director
SNPX Synaptogenix, Inc. Jun 14, 2021 1 $82.6K 4 Jun 16, 2021 Chief Scientific Officer, Director
SNPX Synaptogenix, Inc. Jun 4, 2021 0 $0 3 Jun 14, 2021 Chief Scientific Officer, Director